Pinnacle Biologics, INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.0Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
971clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Harmik Soukiasian | Los Angeles, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $123,271.42 |
| Septimiu Murgu | Chicago, IL | Pulmonary Disease | $80,913.26 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $61,643.17 |
| Omar Awais | Pittsburgh, PA | $34,285.89 | |
| Jonathan Kurman | Milwaukee, WI | Pulmonary Disease | $27,901.85 |
| Wilson Tsai | Walnut Creek, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $26,254.03 |
| Amit Tandon | Wesley Chapel, FL | Critical Care Medicine (Internal Medicine) | $24,862.22 |
| Kamran Ayub | Oak Lawn, IL | Gastroenterology (Internal Medicine) | $24,615.11 |
| Venkatesh Lakshminarayanan | Atlanta, GA | Pulmonary Disease | $23,148.99 |
| Ron Allison | Greenville, NC | Radiation Oncology | $21,200.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.